In turn, compared to those in control mice, the expression levels of CD36, PPARα, and CPT1β were increased in the heart tissues of DCM model mice, and this effect was attenuated in low-dose A-MG-treated mice. This evidence concerns the gene CD36 and familial dilated cardiomyopathy.